Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing

New England Journal of Medicine

Volumn 353, Issue 5, 2005, Pages 460-467

  Busch, Michael P ^a,b,h   Caglioti, Sally ^c   Robertson, Eugene F ^c   McAuley, Joan D ^c   Tobler, Leslie H ^a   Kamel, Hany ^d   Linnen, Jeffrey M ^e,i   Shyamala, Venkatakrishna ^e,f   Tomasulo, Peter ^d   Kleinman, Steven H ^a,g  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Blood Systems Laboratories   (United States)

^d Blood Systems Incorporated   (United States)

^e Gen Probe Incorporated   (United States)

^f NOVARTIS PHARMA AG   (Switzerland)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h Blood Systems   (United States)

ⁱ NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD EXAMINATION; HUMAN; NUCLEIC ACID AMPLIFICATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; VIRUS INFECTION; WEST NILE FLAVIVIRUS; BLOOD; BLOOD TRANSFUSION; CLINICAL TRIAL; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MULTICENTER STUDY; VIREMIA; VIROLOGY;

ANTIBODIES, VIRAL; BLOOD; BLOOD DONORS; BLOOD TRANSFUSION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RNA, VIRAL; VIREMIA; WEST NILE FEVER; WEST NILE VIRUS;

EID: 23044469979     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa044029     Document Type: Article

References (22)

1. Provisional surveillance summary of the West Nile virus epidemic - United States, January-November 2002. MMWR Morb Mortal Wkly Rep 2002;51:1129-33.
2. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA 2003;290:524-8.
3. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003;349:1236-45.
4. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003;349:1205-6.
5. Epstein JS. Insights on donor screening for West Nile virus. Transfusion 2005;45: 460-2.
6. Food and Drug Administration, Center for Biologics Evaluation and Research. Workshop on development of donor screening assays for West Nile Virus, Bethesda, Md., November 4-5, 2002. (Accessed July 8, 2005, at http://www.fda.gov/cber/meetings/ wnv110402.htm.)
7. Hollinger FB, Kleinman S. Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectives. Transfusion 2003;43:992-7.
8. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004;351:760-8.
9. Giachetti C, Linnen JM, Kolk DP, et al. Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 2002;40:2408-19.
10. Busch MP, Tobler LH, Saldanha J, et al. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Transfusion 2005; 45:492-9.
11. Kleinman S, Glynn SA, Busch M, et al. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience. Transfusion 2005;45:469-79.
12. Update: detection of West Nile virus in blood donations - United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52: 916-9. [Erratum, MMWR Morb Mortal Wkly Rep 2003;52:9422E]
13. Prince HE, Hogrefe HR. Detection of West Nile virus (WNV)-specific immunoglobulin M in a reference laboratory setting during the 2002 WNV season in the United States. Clin Diagn Lab Immunol 2003;10: 764-8.
14. Turnbull BW. The empirical distribution function with arbitrarily grouped, censored and truncated data. J R Stat Soc B 1976;38: 290-5.
15. Update: West Nile virus screening of blood donations and transfusion-associated transmission - United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53:281-4.
16. Custer BS, Tomasulo PA, Murphy EL, et al. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion 2004; 44:1547-54.
17. Southam CH, Moore AE. Induced virus infections in man by the Egypt isolates of West Nile virus. Am J Trop Med Hyg 1954;3: 19-50.
18. Ratterree MS, Gutierrez RA, Travassos da Rosa AP, et al. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J Infect Dis 2004;189:669-76.
19. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, Engle M. A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med 2003; 198:1853-62.
20. Marshall DA, Kleinman SH, Wong JB, et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C, and human immunodeficiency virus in the United States. Vox Sang 2004;86:28-40.
21. Krugman S, Ward R, Giles JP, Bodansky O, Jacobs AM. Infectious hepatitis: detection of virus during the incubation period and in clinically inapparent infection. N Engl J Med 1959;261:729-34.
22. Busch MP, Glynn SA, Stramer SL, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005;45:254-64.